-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Singular Genomics Systems, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q2 2020 to Q3 2024.
- Singular Genomics Systems, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2024 was -$18.1M, a 26.4% increase year-over-year.
- Singular Genomics Systems, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2024 was -$93M, a 7.04% increase year-over-year.
- Singular Genomics Systems, Inc. annual Operating Income (Loss) for 2023 was -$103M, a 9.96% decline from 2022.
- Singular Genomics Systems, Inc. annual Operating Income (Loss) for 2022 was -$93.5M, a 52.6% decline from 2021.
- Singular Genomics Systems, Inc. annual Operating Income (Loss) for 2021 was -$61.3M, a 123% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)